Market Tracker

09/18 5:26am ET

Novavax Inc (NASDAQ:NVAX)

4.59
Data as of Sep 17
 +0.09 / +2.00%
Today’s Change
2.68
Today|||52-Week Range
6.95
-10.35%
Year-to-Date

Today’s Trading

Previous close4.50
Today’s open4.53
Day’s range-- - --
Volume2,828,138
Average volume (3 months)3,028,925
Market cap$1.1B
Dividend yield--
Data as of 09/17/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)+10.27%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book4.62

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc-0.39-1.45%
BLUEbluebird bio Inc-0.09-0.25%
HALOHalozyme Therapeutic...+0.84+9.29%
AEGRAegerion Pharmaceuti...+1.28+3.95%
Data as of 09/17/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
SVP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts